PYRAZOLE AMIDE DERIVATIVE

The present invention relates to a novel compound having a function of inhibiting RORγ activity. The present invention also relates to pharmaceutical composition comprising the compound, a use of the compound in treating or preventing autoimmune diseases, inflammatory diseases, metabolic diseases, o...

Full description

Saved in:
Bibliographic Details
Main Authors CEE, VICTOR J, KAKUDA, SHINJI, BOOKER, SHON KEITH, BREGMAN, HOWARD, CHAKKA, NAGASREE, SHIMADA, KEIKO, OLSON, STEVEN H, HUA, ZIHAO, PENNINGTON, LEWIS D, BECK, HILARY PLAKE, HIRATA, JUN, WHITE, RYAN D, WURZ, RYAN P, FOX, BRIAN M, HIBIYA, KENTA, OKADA, KAZUHISA, YI, SHUYAN, OONO, HIROYUKI, SASAKI, KOSUKE, LOPEZ, PATRICIA, NAKAJIMA, RYOTA, CUSHING, TIMOTHY D, HAO, XIAOLIN, SHIN, YOUNGSOOK, GEUNS-MEYER, STEPHANIE, HUMAN, JASON, ZHENG, XIAO MEI, EPSTEIN, OLEG
Format Patent
LanguageEnglish
French
Published 03.09.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to a novel compound having a function of inhibiting RORγ activity. The present invention also relates to pharmaceutical composition comprising the compound, a use of the compound in treating or preventing autoimmune diseases, inflammatory diseases, metabolic diseases, or cancer diseases. La présente invention concerne un nouveau composé ayant une fonction d'inhibition de l'activité RORγ. La présente invention concerne également une composition pharmaceutique comprenant le composé, une utilisation du composé dans le traitement ou la prévention de maladies auto-immunes, de maladies inflammatoires, de maladies métaboliques, ou de maladies cancéreuses.
Bibliography:Application Number: WO2015JP56584